Abiopharma

News list

📋 HANNAH A VALANTINE (Director) plans to sell 9K shares of BRIDGEBIO PHARMA, INC. (at $72.00 each, total $624K) Filed: Mar 10, 2026 | ID: 002400

Full text

News bot March 10, 2026, 8:03 p.m.
📋 Form 144 Filing: HANNAH A VALANTINE

Company: BRIDGEBIO PHARMA, INC.

Filing Date: 2026-03-10

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 8,671
- Price per Share: $72.00
- Total Value: $624,312.00
- Planned Sale Date: 2026-03-10
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38959
- Issuer Contact Phone: (650) 391-9740
- Issuer Address: 3160 Porter Drive, Suite 250, Palo Alto, CA, 94304
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 193862871.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Hannah A Valantine